ES2530140B1 - Combinación para disminuir la hiperpigmentación de la piel - Google Patents

Combinación para disminuir la hiperpigmentación de la piel Download PDF

Info

Publication number
ES2530140B1
ES2530140B1 ES201331146A ES201331146A ES2530140B1 ES 2530140 B1 ES2530140 B1 ES 2530140B1 ES 201331146 A ES201331146 A ES 201331146A ES 201331146 A ES201331146 A ES 201331146A ES 2530140 B1 ES2530140 B1 ES 2530140B1
Authority
ES
Spain
Prior art keywords
combination
composition
skin hyperpigmentation
topical
decrease skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn - After Issue
Application number
ES201331146A
Other languages
English (en)
Other versions
ES2530140A1 (es
Inventor
Carles Trullàs Cabanas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Isdin SA
Original Assignee
Isdin SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isdin SA filed Critical Isdin SA
Priority to ES201331146A priority Critical patent/ES2530140B1/es
Priority to PCT/ES2014/070362 priority patent/WO2015011311A1/es
Publication of ES2530140A1 publication Critical patent/ES2530140A1/es
Application granted granted Critical
Publication of ES2530140B1 publication Critical patent/ES2530140B1/es
Withdrawn - After Issue legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/884—Sequential application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Abstract

Combinación para disminuir la hiperpigmentación de la piel.#Se refiere al uso de una combinación que comprende extracto de corteza de pino y extracto de semilla de uva para la preparación de una composición oral para disminuir la hiperpigmentación de la piel, donde dicha composición se administra secuencial o separadamente en combinación con una composición tópica que comprende feniletilresorcinol, niacinamida y tetrapéptido-30 junto con uno o más excipientes y/o portadores aceptables para uso tópico. También se refiere a un kit que comprende una composición oral y una composición tópica con los mencionados componentes.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21
imagen22

Claims (1)

  1. imagen1
    imagen2
    imagen3
ES201331146A 2013-07-26 2013-07-26 Combinación para disminuir la hiperpigmentación de la piel Withdrawn - After Issue ES2530140B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201331146A ES2530140B1 (es) 2013-07-26 2013-07-26 Combinación para disminuir la hiperpigmentación de la piel
PCT/ES2014/070362 WO2015011311A1 (es) 2013-07-26 2014-04-24 Combinación para disminuir la hiperpigmentación de la piel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201331146A ES2530140B1 (es) 2013-07-26 2013-07-26 Combinación para disminuir la hiperpigmentación de la piel

Publications (2)

Publication Number Publication Date
ES2530140A1 ES2530140A1 (es) 2015-02-26
ES2530140B1 true ES2530140B1 (es) 2015-12-28

Family

ID=52392770

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201331146A Withdrawn - After Issue ES2530140B1 (es) 2013-07-26 2013-07-26 Combinación para disminuir la hiperpigmentación de la piel

Country Status (2)

Country Link
ES (1) ES2530140B1 (es)
WO (1) WO2015011311A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3928760A1 (en) * 2020-06-23 2021-12-29 Chanda Zaveri Skin lightening formulations

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11071701B2 (en) 2016-06-30 2021-07-27 Symrise Ag Medicament and cosmetic composition comprising resorcinol derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0417904A (pt) * 2004-01-24 2007-04-10 Unilever Nv produto de clareamento de pele, métodos de aumentar a relação de melanina clara para melanina escura na pele de um mamìfero, e de modular a produção de melanina na pele de um mamìfero, e, uso de um produto
US20080305059A1 (en) * 2007-06-06 2008-12-11 Chaudhuri Ratan K Skin lightening compositions and methods
EP2065029B1 (en) * 2007-11-30 2013-04-17 Evonik Goldschmidt GmbH Personal care and cosmetic composition containing tetrapeptides with the motifs GX1X2G, PX1X2P, or PX1X2K
US8075931B2 (en) * 2009-10-02 2011-12-13 Johnson & Johnson Consumer Companies, Inc. Extracts of Phyllanthus niruri
CA2932130C (en) * 2011-01-07 2019-07-09 Allergan, Inc. Compositions comprising substituted benzaldehydes and use thereof for lightening skin or treating hyperpigmenation and hypermelanosis disorders
CN102871863B (zh) * 2012-10-24 2014-04-09 成都瑞商通银日用品有限公司 一种美白补水复合物

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3928760A1 (en) * 2020-06-23 2021-12-29 Chanda Zaveri Skin lightening formulations
US11596665B2 (en) 2020-06-23 2023-03-07 Chanda Zaveri Skin lightening formulations

Also Published As

Publication number Publication date
WO2015011311A1 (es) 2015-01-29
ES2530140A1 (es) 2015-02-26

Similar Documents

Publication Publication Date Title
ES2533145B1 (es) Procedimiento cosmético para reducir el tejido adiposo subcutáneo
ES2637421T3 (es) Composiciones tópicas que comprenden variantes de pliegue-OB
CL2016001544A1 (es) Composición dentífrica que comprende óxido de zinc y citrato de zinc
ES2483725T3 (es) Composición básica cosmética y su uso
CL2016001547A1 (es) Composiciones para el cuidado oral
CL2013000801A1 (es) Composicion farmaceutica que comprende un inhibidor de rankl y una hormona o un derivado de la misma, y uso del inhibidor rankl para preparar dicha composicion
IT1400858B1 (it) Uso di un estratto vegetale ricco di polifenoli come agente antiossidante in associazione con un agente idratante oppure umettante.
ES2620754T3 (es) Uso de 5-androstano (alquil)-3,5,6-triol en la preparación de fármacos neuroprotectores
ES2552654T3 (es) Uso de LCAT para tratar la anemia y la disfunción de los glóbulos rojos
CL2013001324A1 (es) Kit que comprende ec145 y uno o mas agentes quimioterapéuticos adicionales; uso para tratar un cancer.
NI201500063A (es) Tratamiento de cáncer con pomalidomida en un individuo con daño renal
CL2013002224A1 (es) Formulación que comprende (a) un extracto de reynoutria sachalinensis que comprende uno o más derivados de antraquinona y (b) una lignina; uso de dicha formulación, en métodos para combatir hongos fitopatógenos.
ES2508165T3 (es) Lactoferrina y sustancia blanca
NI201500175A (es) Compuestos nuevos para el tratamiento del cáncer
CL2015001564A1 (es) Composición que comprende una triazina y su uso en el tratamiento intramuscular de coccidiosis o enfermedad protozoaria relacionada, en un mamífero no humano.
UY32414A (es) Nuevos metodos
ES2530140B1 (es) Combinación para disminuir la hiperpigmentación de la piel
ES2517741B1 (es) Composición para reducir y/o prevenir la caída del cabello y/o estimular su crecimiento
BR112013024606A2 (pt) composição, kit farmacêutico, e, métodos para o tratamento de uma condição de pele, e para preparar uma composição
SV2010003773A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
CO6531499A2 (es) Uso de ranolazina para el tratameinto de enfermedades cardiovasculares
CL2014003484A1 (es) Uso de nalmefeno en la reduccion del consumo de alcohol en un paciente con dependencia del alcohol; composicion farmaceutica oral; combinacion farmaceutica.
BR112015006959A2 (pt) Uso cosmético, processo cosmético e conjunto
CO6541630A2 (es) Combinación teobromina con un descongestivo y su uso para el tratamiento de la tos
ECSP12011951A (es) Uso de una fuente de l3 y/o l5 como vacuna o como diagnóstico para una enfermedad parasitaria

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2530140

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20151228

FA2A Application withdrawn

Effective date: 20160518